Post-earnings recap
Reported
Thu, Aug 4, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
Eli Lilly's earnings report showed a significant miss on EPS, which contributed to a 2.56% decline in stock price. The company did not provide revenue figures or guidance, leaving investors uncertain about future performance. The management's cautious tone suggests they are aware of the challenges ahead but are committed to long-term strategies.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.25 | N/A | -30.67% |
Management expressed concerns over recent performance but remains focused on future opportunities. They did not provide specific guidance for the upcoming quarters.
Management acknowledged the challenges faced this quarter.
They emphasized a focus on long-term growth despite current setbacks.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—